ADEONA PHARMACEUTICALS, INC.

Company

Theriva Biologics, Inc.

Filed

January 28, 2011

Accession Number

0000902664-11-000052

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →